FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 291

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
BCTX Nasdaq BriaCell Therapeutics Corp. 2830
BDX New York Becton, Dickinson and Company 2830
BHST Nasdaq BioHarvest Sciences Inc. 2830
BHVN New York Biohaven Ltd. 2830
BIOA Nasdaq BioAge Labs, Inc. 2830
BMRN Nasdaq BioMarin Pharmaceutical Inc. 2830
BMY New York Bristol-Myers Squibb Company 2830
BOLD Nasdaq Boundless Bio, Inc. 2830
BPTH Nasdaq Bio-Path Holdings, Inc. 2830
BYSI Nasdaq BeyondSpring Inc. 2830
CALC Nasdaq CalciMedica, Inc. 2830
CAMP Nasdaq Camp4 Therapeutics Corporation 2830
CANF NYSE American Can-Fite BioPharma Ltd. 2830
CARM Nasdaq Carisma Therapeutics, Inc. 2830
CATX NYSE American Perspective Therapeutics, Inc. 2830
CCCC Nasdaq C4 Therapeutics, Inc. 2830
CDT Nasdaq Conduit Pharmaceuticals Inc. 2830
CDXC Nasdaq ChromaDex Corporation 2830
CDXS Nasdaq Codexis, Inc. 2830
CELZ Nasdaq Creative Medical Technology Holdings, In 2830
CGC Nasdaq Canopy Growth Corporation 2830
CHGCY Over the counter Chugai Pharmaceutical Co., Ltd. 2830
CHRO NYSE American Channel Therapeutics Corporation 2830
CING Nasdaq Cingulate Inc. 2830
CLDX Nasdaq Celldex Therapeutics, Inc. 2830
CLNN Nasdaq Clene Inc. 2830
CLRB Nasdaq Cellectar Biosciences, Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CMPX Nasdaq Compass Therapeutics, Inc. 2830
CNSP Nasdaq CNS Pharmaceuticals, Inc. 2830
CNTX Nasdaq Context Therapeutics Inc. 2830
COGT Nasdaq Cogent Biosciences, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CPIX Nasdaq Cumberland Pharmaceuticals Inc. 2830
CPRX Nasdaq Catalyst Pharmaceuticals, Inc. 2830
CRBU Nasdaq Caribou Biosciences, Inc. 2830
CRL New York Charles River Laboratories International 2830
CRMD Nasdaq CorMedix Inc. 2830
CRON Nasdaq Cronos Group Inc. 2830
CRSP Nasdaq CRISPR Therapeutics AG 2830
CRVS Nasdaq Corvus Pharmaceuticals, Inc. 2830
CSLLY Over the counter CSL Limited 2830
CTMX Nasdaq CytomX Therapeutics, Inc. 2830
CTNM Nasdaq Contineum Therapeutics, Inc. 2830
CTOR Nasdaq Citius Oncology, Inc. 2830
CVM NYSE American CEL-SCI Corporation 2830
DNLI Nasdaq Denali Therapeutics Inc. 2830
DRMA Nasdaq Dermata Therapeutics, Inc. 2830
DRTS Nasdaq Alpha Tau Medical Ltd. 2830
DSNKY Over the counter Daiichi Sankyo Company, Limited 2830
Results 50 through 100 of 291